NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Khalil Choucair
University of Kansas - Lawrence / United States
Medical and Health Sciences / Hematology
AD Scientific Index ID: 1541117
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Khalil Choucair's MOST POPULAR ARTICLES
1-)
Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapyA Alqahtani, K Choucair, M Ashraf, DM Hammouda, A Alloghbi, T Khan, ...Future science OA 5 (3), FSO372, 20192212019
2-)
TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trialsK Choucair, S Morand, L Stanbery, G Edelman, L Dworkin, J NemunaitisCancer gene therapy 27 (12), 841-853, 2020972020
3-)
PTENgenomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activityK Choucair, J Ejdelman, F Brimo, A Aprikian, S Chevalier, J LapointeBMC cancer 12, 1-9, 2012962012
4-)
Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinibJ Nemunaitis, S Bauer, JY Blay, K Choucair, H Gelderblom, S George, ...Future Oncology 16 (1), 4251-4264, 2019602019
5-)
Natural killer cells: a review of biology, therapeutic potential and challenges in treatment of solid tumorsK Choucair, JR Duff, CS Cassidy, MT Albrethsen, JD Kelso, A Lenhard, ...Future oncology 15 (26), 3053-3069, 2019542019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept